EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diabetic Retinopathy and Regulation of Mitochondrial Glutathione–Glutathione Peroxidase Axis in Hyperhomocysteinemia

Pooja Malaviya, Renu A Kowluru iD

Antioxidants · 20.02.2024 · 13 (3) · 254

DOI: 10.3390/antiox13030254 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 20.02.2024. Verfasst von Pooja Malaviya und 1 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology, Visual and Anatomical Sciences, Wayne State University, Detroit, MI 48202, USA. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic patients have elevated homocysteine levels, and hyperhomocysteinemia is shown to exacerbate mitochondrial damage, which plays a central role in diabetic retinopathy. Glutathione peroxidases (GPx) catalyze hydrogen peroxide (H2O2) reduction using glutathione (GSH) as a cofactor. GSH and GPx are mainly cytosolic but are also present in the mitochondria to neutralize H2O2 produced by superoxide dismutase, and in diabetes, they are downregulated. Hyperhomocysteinemia also disrupts the balance between S-adenosyl-L-homocysteine and S-adenosylmethionine (SAM); SAM is also a methyl donor for DNA methylation. The aim of this study was to investigate the role of homocysteine in mitochondrial GSH–GPx1 regulation in diabetic retinopathy. Human retinal endothelial cells in 20 mM D-glucose + high homocysteine were analyzed for ROS, GSH and GPx in the mitochondria, and SAM levels and GPx1 promoter DNA methylation were also studied (5-methylcytosine and MS-PCR). The results were confirmed in the retina from streptozotocin-induced hyperhomocysteinemic (cystathionine-β-synthase-deficient) diabetic mice. High homocysteine exacerbated the glucose-induced decrease in GSH levels and GPx activity in the mitochondria and the downregulation of GPx1 transcripts and further increased SAM levels and GPx1 promoter DNA methylation. Similar results were obtained in a hyperglycemic–hyperhomocysteinemic mouse model. Thus, elevated homocysteine in diabetes hypermethylates GPx1 promoter, thus decreasing the mitochondrial GPx/GSH pool and exacerbating mitochondrial damage. Modulating hyperhomocysteinemia could be a potential therapeutic avenue to target mitochondrial dysfunction in diabetic retinopathy.

Schlagwörter

Stichwörter der Autor:innen

DNA methylationdiabetic retinopathyglutathionehomocysteinemitochondriaperoxidase

Autor:innen und Institutionen

  • Ophthalmology, Visual and Anatomical Sciences, Wayne State University, Detroit, MI 48202, USA.
  • Kresge Eye Institute, Wayne State University, Detroit, MI 48201, USA.

ORCID-Profile: Renu A Kowluru

Förderung

  • NEI NIH HHS
  • NIH HHS
  • National Institutes of Health
  • The Thomas Foundation
  • Department of Ophthalmology, Wayne State University

Zitieren

APA

Malaviya, P., & Kowluru, R. A. (2024). Diabetic Retinopathy and Regulation of Mitochondrial Glutathione–Glutathione Peroxidase Axis in Hyperhomocysteinemia. Antioxidants, 13(3), 254. https://doi.org/10.3390/antiox13030254

Vancouver

Malaviya P, Kowluru RA. Diabetic Retinopathy and Regulation of Mitochondrial Glutathione–Glutathione Peroxidase Axis in Hyperhomocysteinemia. Antioxidants. 2024;13(3):254. doi:10.3390/antiox13030254

BibTeX
@article{Malaviya2024,
  author = {Malaviya, Pooja and Kowluru, Renu A},
  title = {Diabetic Retinopathy and Regulation of Mitochondrial Glutathione–Glutathione Peroxidase Axis in Hyperhomocysteinemia},
  journal = {Antioxidants},
  year = {2024},
  volume = {13},
  number = {3},
  pages = {254},
  doi = {10.3390/antiox13030254}
}
Kostenlos starten →